Twenty-year experience of radical cystectomy for bladder cancer in a medium-volume centre

Scandinavian Journal of Urology and Nephrology

Volumn 43, Issue 5, 2009, Pages 357-364

  Bostrm, Peter J ^a   Mirtti, Tuomas ^b   Kssi, Jyrki ^c   Laato, Matti ^a   Nurmi, Martti ^a  

^a Division of Urology   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

Bladder cancer; Follow up; Lymphadenectomy; Radical cystectomy; Risk factor; Survival

Indexed keywords

ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; CANCER CENTER; CANCER CONTROL; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER THERAPY; CONTROLLED STUDY; CYSTECTOMY; DISTANT METASTASIS; FEMALE; FOLLOW UP; GENDER; HUMAN; KIDNEY FUNCTION; LOCAL METASTASIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SMOKING; SURVIVAL TIME; URETHRA; URINARY TRACT;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CYSTECTOMY; FEMALE; FINLAND; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 70450202552     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365590902939387     Document Type: Article

References (25)

1. Finnish Cancer Registry. Available from: http://www.cance rregistry.fi/eng/statistics/
2. Liedberg F, Ma°nsson W. Lymph node metastasis in bladder cancer. Eur Urol 2006;/49:/13-21.
3. Sternberg C, Donat S, Bellmunt J, Millikan R, StadlerW, De Mulder P, et al. Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. Urology 2007;/69(1 Suppl):/62-79.
4. Herr H, Dotan Z, Donat S, Bajorin D. Defining optimal therapy for muscle invasive bladder cancer. J Urol 2007;/177:/ 437-443
5. Boström P, Kössi J, Laato M, Nurmi M. Risk factors for mortality and morbidity related to radical cystectomy. BJU Int 2008; July.
6. Sobin LH, Wittekind C. UICC (2002) TNM classification of malignant tumors. 6th ed. New York: Wiley and Sons; 2002.
7. Mostofi FK, Sobin LH. Histologic typing of urinary bladder tumors. Geneva: World Health Organization; 1973.
8. Hautmann R, Gschwend J, de Petriconi R, Kron M, Volkmer B. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 2006;/176:/486-92.
9. Madersbacher S, Hochreiter W, Burkhard F, Thalmann G, Danuser H, Markwalder R, et al. Radical cystectomy for bladder cancer today- a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003;/21:/690-6.
10. Stein J, Lieskovsky G, Cote R, Groshen S, Feng A, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;/19:/666-75.
11. Shariat S, Karakiewicz P, Palapattu G, Lotan Y, Rogers C, Amiel G, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: A contemporary series from the Bladder Cancer Research Consortium. J Urol 2006;/176:/2414-22. (Pubitemid 44755069)
12. Dhar N, Klein E, Reuther A, Thalmann G, Madersbacher S, Studer U. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008;/179:/ 873-878
13. Brausi M. The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancer. Eur Urol 2007;/51:/1435-6.
14. Whelan P. The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancer. Eur Urol 2007;/51:/1436-7.
15. Stroumbakis N, Herr H, Cookson M, Fair W. Radical cystectomy in the octogenarian. J Urol 1997;/158:/2113-7.
16. Soulié M, Straub M, Gamé X, Seguin P, De Petriconi R, Plante P, et al. A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer. J Urol 2002;/167:/1325-8.
17. Clark P, Stein J, Groshen S, Cai J, Miranda G, Lieskovsky G, et al. Radical cystectomy in the elderly: comparison of clinical outcomes between younger and older patients. Cancer 2005;/104:/36-43.
18. Sved P, Gomez P, Nieder A, Manoharan M, Kim S, Soloway M. Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors. BJU Int 2004;/94:/785-9.
19. Nieder A, Sved P, Gomez P, Kim S, Manoharan M, Soloway M. Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring. Urology 2004;/ 64:/950-4.
20. Huguet J, Monllau V, Sabaté S, Rodriguez-Faba O, Algaba F, Palou J, et al. Diagnosis, risk factors, and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients. Eur Urol 2008;/53:/785-92.
21. Volkmer BG, Bartsch G, Kuefer R, Hautmann RE. Oncologic follow-up after radical cystectomy: is there any benefit? J Urol 2008;/179:/582.
22. Dhar N, Klein E, Reuther A, Thalmann G, Madersbacher S, Studer U. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008;/179:/ 873-878
23. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial. International collaboration of trialists. Lancet 1999;354:533-540
24. Winquist E, Kirchner T, Segal R, Chin J, Lukka H. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: A systematic review and meta-analysis. J Urol 2004;/171:/561-9.
25. Shariat S, Karakiewicz P, Ashfaq R, Lerner S, Palapattu G, Cote R, et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer 2008;/112:/315-25.